A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Li, Da ^a   Bi, Fang Fang ^a   Chen, Na Na ^b   Cao, Ji Min ^c   Sun, Wu Ping ^d   Zhou, Yi Ming ^d   Li, Chun Yan ^c   Yang, Qing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN 1;

BIOSYNTHESIS; DNA METHYLATION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MUTATION; OVARY TUMOR; PATHOLOGY; PRIMARY CELL CULTURE; TUMOR CELL LINE;

BRCA1 PROTEIN; CELL LINE, TUMOR; DNA METHYLATION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NAD; OVARIAN NEOPLASMS; PRIMARY CELL CULTURE; SIRTUIN 1;

EID: 84929342371     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06666     Document Type: Article

References (28)

1. Lech, A. et al. Ovarian cancer as a genetic disease. Front. Biosci. 18, 543-563 (2013).
2. Pruthi, S., Gostout, B. S. & Lindor, N. M. Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin. Proc. 85, 1111-1120 (2010).
3. Dacheux, E. et al. BRCA1-Dependent Translational Regulation in Breast Cancer Cells. PLoS One 8, e67313 (2013).
4. Bi, F. F., Li, D. & Yang, Q. Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer. BMC Cancer 13, 90 (2013).
5. Fang, Y. Y., Li, D., Cao, C., Li, C. Y. & Li, T. T. Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer. BMC Cancer 14, 188 (2014).
6. Li, D. et al. Poly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancer. Oncotarget 5, 291-297 (2014).
7. Li, D. et al. Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer. J. Exp. Clin. Cancer Res. 32, 102 (2013).
8. Li, D. et al. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation. Mol. Cancer 13, 26 (2014).
9. Li, D. et al. Epigenetic repression of phosphatidylethanolamine, N-methyltransferase (PEMT) in BRCA1-mutated breast cancer. Oncotarget 5, 1315-25 (2014).
10. Revollo, J. R. & Li, X. The ways and means that fine tune Sirt1 activity. Trends Biochem. Sci. 38, 160-167 (2013).
11. Sun, L. et al. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells. J. Cell Sci. 126, 3939-47 (2003).
12. Menendez, J. A., Mehmi, I., Atlas, E., Colomer, R. & Lupu, R. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Int. J. Oncol. 24, 591-608 (2004).
13. Tang, M. K. et al. BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency intumorigenesis. Cancer Lett. 346, 139-147 (2014).
14. Marks, J. R. Refining the role of BRCA1 in combating oxidative stress. Breast Cancer Res. 15, 320 (2013).
15. Zou, J., Rezvani, K., Wang, H., Lee, K. S. & Zhang, D. BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress. Cell Cycle 12, 2255-2265 (2013).
16. Chang, H. C. & Guarente, L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 25, 138-145 (2014).
17. Li, D. et al. BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer. Cell Cycle 13, 2564-2571 (2014).
18. Martinez-Outschoorn, U. E. et al. Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFkappaB activation in the tumor stroma. Cell Cycle 11, 4152-4166 (2012).
19. Ou, X., and Lee, M. R., Huang, X., Messina-Graham, S. & Broxmeyer, H. E. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 32, 1183-1194 (2014).
20. Fan, S., Meng, Q., Auborn, K., Carter, T. & Rosen, E. M. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br. J. Cancer 94, 407-426 (2006).
21. Jung, T.W., Lee, K.T., Lee, M.W. &Ka, K.H.SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. Biochem. Biophys. Res. Commun. 422, 229-232 (2012).
22. Lee, J. et al. Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism. Cell Stress Chaperones 19, 649-656 (2014).
23. Chiarugi, A., Dolle, C., Felici, R. & Ziegler, M. The NAD metabolome - a key determinant of cancer cell biology. Nat. Rev. Cancer 12, 741-752 (2012).
24. Han, C. et al. Role of mammalian sirtuin 1 (SIRT1) in lipids metabolism and cell proliferation of goose primary hepatocytes. Mol. Cell Endocrinol. 382, 282-291 (2014).
25. Burga, L. N. et al. Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers. Cancer Res. 69, 1273-1278 (2009).
26. Promkan, M., Liu, G., Patmasiriwat, P. & Chakrabarty, S. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells. Int. J. Cancer 125, 2820-2828 (2009).
27. Hiraike, H. et al. Identification of DBC1 as a transcriptional repressor for BRCA1. Br. J. Cancer 102, 1061-1067 (2010).
28. Wang, R. H. et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol. Cell 32, 11-20 (2008).